Noscam

Noscam

ICO Ended
14,338 Views
NOSCAM-Scam projects searching platform

A work of NOSCAM platform on searching SCAM projects is based on so called “Crowd wisdom”. Our followers will be investigating each project and estimating in the end whether it’s SCAM or NOSCAM. After that, taking into account that data, our team will be making an analysis of an ICO project in accordance with such criteria as the project necessity, team’s competency and etc.

If points of view of the team and the crowd are identical, there will be published a verdict in our social groups. There is going to be launched a mobile application in Q3, 2018 for more convenient voting process.



Why will the crowd vote? Everybody will get NSC token for his voice. That’s why both parties are pleased: as one which votes for the projects on NOSCAM platform as another one which is going to invest money to the projects.
5.6
TOTAL SCORE
5.8
ICO PROFILE

(weight: 45%)

1
TEAM PROOF

(weight: 20%)

Get widget
General
Website: Visit
White paper: Read
Bounty: Bounty
ICO Time: 15 Apr 2018 - 30 May 2018
Country: Ukraine
Token info
Ticker: NSC
Platform: Ethereum
Token Type: ERC20
Available for sale: 2,250,000,000 NSC (75%)
Financial
ICO Price: 1 NSC = 0.01 USD
Accepting: ETH
Q4 2017
Formation of the team.
Q1-Q2 2018
People base formation for voting.
Q1 2018
Bounty company.
Q2 2018
ICO.
Q3 2018
Testing and launching a mobile voting application NOSCAM.
Q3 2018
Listing on the exchange.
Q4 2018
Invitation of two developers.
Q1 2019
Start the development of a decentralized NOSCAM application.
Screenshots taken on 29 Mar 2018
Sergei Ivanov
Project leader and developer Ukraine
No participating data
Vladislav Kuchmin
Product Designer Ukraine
No participating data
Maksim Krasnokutskiy
Developer Russia
No participating data
Lily Lee
Marketing Europe
No participating data

Advisors (0)

HEIGHT - 0px
WIDTH - 0px
PUT THIS CODE TO YOUR WEBSITE
ICO List
Other Interesting ICOs
Active
Rivalz
Rivalz is redefining AI infrastructure by creating an AI Intel Layer to unlock new agentic economies. Built on a dual-chain DePIN architecture using Dymension and Arbitrum, Rivalz addresses one of the biggest bottlenecks in AI today: access to AI-ready, verifiable, and secure data. As we envision the web3 space to become agentic and overtake humans in the amount of transactions over time, what Rivalz is building is key for enabling this future. The core challenge that Rivalz is addressing is the need for AI-ready, verifiable and accessible data and later on intelligence. Rivalz offers a hybrid solution combining decentralized storage and high-speed agent-centric connectivity networks that cater specifically to AI's demands, ushering in the era of the agentic economy.
Upcoming
Aimedis
Aimedis is an AI backed, blockchain and smart contract supported medical ecosystem, that changes the way patients, doctors, and hospitals communicate, connect and handle information. Using the Aimedis platform, users can store, secure and share their medical information only with the people they want to share it with by using the Aimedis right management system. Beside the records, AImedis offers videochat and communication with other patients and doctors, online prescriptions, online appointments, learning content, the inclusion of fitness trackers and devices like ECG or bloodpressure monitors into the system, while all transactions inside the system are backed by our porprietary private AIMChain blockchain, while the token is bound to a public blockchain (Aimedis dual-blockchain model). AIMSocial will be the new incentivised and decentralized medical social network where patients can help other patients and get rewarded for it, while the system is supported by AI.
Upcoming
Fan360
The first sports community for fans, that covers the complete fan experience. Follow your favourite sports star, club or brand and get rewarded for engaging.
Pre-Sale
2GETHER
2gether is developing the bank of the future, a future where; consumers take full ownership and control of the services they use, move beyond solely interacting with euros and dollars and fully embrace cryptocurrencies and digital assets, and augment their financial decisions through the use of exponential technologies like artificial intelligence, big data and blockchain. We are on a mission to change the way people interact with their finances. We are building a modern mutual organisation where everyone is an owner of their banking experience.
Upcoming
Quantler
Quantler is a blockchain for creating, analysing, sharing and running of decentralized structured investment products. Create structured products (such as an ETF) in equities or cryptocurrencies using themes. As there are a lot of the tokenized products being launched (currently over 1 900 available) the structured products for these assets are lacking behind (such as sector-based ETFs). Using Quantler’s blockchain anyone can create structured products (for regular assets such as Equities and cryptocurrencies) and run them on a decentralized network (much like smart contracts). Quantler also allows for regular assets, for this market Quantler’s solution is more flexible and has a lower costs base (targeted for exchanges, family offices and investment managers). The QUANT token’s intrinsic value is dependent on the AUM (asset under management) by the entire network. Quantler is like a Vanguard or BlackRock, but then in the form of a network.
Upcoming
Pharmeum
Pharmeum is the world's first blockchain-based prescription platform with AI health analytics, which is currently working alongside the National Health Service (NHS) in England. The Pharmeum platform is an inter-operable, decentralised, digital prescription platform running over an intelligent neural network. Empowering patients’ ownership of their medication history, and enabling affordable access to healthcare globally. Medical errors and late diagnoses are minimised by using a permissioned blockchain integrated with artificial intelligence. Pharmeum is an advanced, digitised, health eco-system.The Pharmeum blockchain will improve medicine affordability, minimise errors, and create frictionless, quality care for patients.